← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. New Genomic Techniques and Management of Multidrug-resistant Tuberculosis (2022-03-29) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis (2022-01-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes (2022-01-21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycobacterial infections in solid organ transplant recipients. (2021/12/31) ♡
• Inducible knockdown of Mycobacterium smegmatis MSMEG_2975 (glyoxalase II) affected bacterial growth, antibiotic susceptibility, biofilm, and transcriptome. (2021/12/29) ♡
• In Silico Drug Designing for ala438 Deleted Ribosomal Protein S1 (RpsA) on the Basis of the Active Compound Zrl15. (2021/12/29) ♡
• Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis. (2021/12/29) ♡
• Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia. (2021/12/28) ♡
• Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana. (2021/12/28) ♡
• Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant Mycobacterium tuberculosis CAS1-Kili Strains in Lusaka, Zambia. (2021/12/28) ♡
• The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant Mycobacterium tuberculosis Strains. (2021/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem? (2021/12/24) ♡
• Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India. (2021/12/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. (2021/12/22) ♡
• The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung. (2021/12/22) ♡
• Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical Device. (2021/12/22) ♡
• An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine. (2021/12/22) ♡
• Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010-2017. (2021/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. (2021/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of transmission and disease caused by Mycobacterium caprae and Mycobacterium bovis in Lima, Peru. (2021/12/20) ♡
• Transcriptome signature of cell viability predicts drug response and drug interaction in Mycobacterium tuberculosis. (2021/12/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study. (2021/12/20) ♡
• Integrative utility of long read sequencing-based whole genome analysis and phenotypic assay on differentiating isoniazid-resistant signature of Mycobacterium tuberculosis. (2021/12/18) ♡
• Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study. (2021/12/18) ♡
• Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor. (2021/12/18) ♡
• Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis among Congolese patients. (2021/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem. (2021/12/17) ♡
• Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review. (2021/12/16) ♡
• Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis. (2021/12/16) ♡
• DNA Methyltransferase HsdM Induce Drug Resistance on Mycobacterium tuberculosis via Multiple Effects. (2021/12/16) ♡
• Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria. (2021/12/16) ♡
• Profile of Children With Tuberculosis in a Pediatric Intensive Care Unit in Mumbai. (2021/12/15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis. (2021/12/15) ♡
• Effect of targeted nursing intervention plus psychological counseling on quality of life, negative emotions, and complications in patients with extensively drug-resistant tuberculosis. (2021/12/15) ♡
• A Retrospective Comparative Study on Median Time to Sputum Culture Conversion in Multi-Drug Resistant Pulmonary Tuberculosis Patients in Pastoral and Non-Pastoral Settings in Southeast Oromia, Ethiopia. (2021/12/14) ♡
• Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid. (2021/12/14) ♡
• Validity of automated audiometry for hearing examination in patients with multidrug-resistant tuberculosis. (2021/12/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments. (2021/12/13) ♡
• [Evaluation of screening strategies of multidrug-resistant tuberculosis among pulmonary tuberculosis patients of the different risk levels]. (2021/12/10) ♡
• Barriers to Treatment Compliance of Directly Observed Treatment Shortcourse among Pulmonary Tuberculosis Patients. (2021/12/10) ♡
• Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity. (2021/12/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach. (2021/12/09) ♡
• Distinguishing Relapse From Reinfection With Whole-Genome Sequencing in Recurrent Pulmonary Tuberculosis: A Retrospective Cohort Study in Beijing, China. (2021/12/08) ♡
• Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase. (2021/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults. (2021/12/08) ♡
• Structural Rigidification of N-Aryl-pyrroles into Indoles Active against Intracellular and Drug-Resistant Mycobacteria. (2021/12/08) ♡
• Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. (2021/12/06) ♡
• Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia. (2021/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections. (2021/12/06) ♡
• Sirtuin 7 Regulates Nitric Oxide Production and Apoptosis to Promote Mycobacterial Clearance in Macrophages. (2021/12/03) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.